RAJAGOPAL SEKHAR to Antiretroviral Therapy, Highly Active
This is a "connection" page, showing publications RAJAGOPAL SEKHAR has written about Antiretroviral Therapy, Highly Active.
Connection Strength
0.322
-
Effects of rosiglitazone on abnormal lipid kinetics in HIV-associated dyslipidemic lipodystrophy: a stable isotope study. Metabolism. 2011 Jun; 60(6):754-60.
Score: 0.077
-
Heart positive: design of a randomized controlled clinical trial of intensive lifestyle intervention, niacin and fenofibrate for HIV lipodystrophy/dyslipidemia. Contemp Clin Trials. 2006 Dec; 27(6):518-30.
Score: 0.058
-
HIV-associated lipodystrophy syndrome: an accelerated form of the metabolic syndrome of insulin resistance due to altered fat distribution. Res Initiat Treat Action. 2006; 12(1):5-11.
Score: 0.056
-
Severely dysregulated disposal of postprandial triacylglycerols exacerbates hypertriacylglycerolemia in HIV lipodystrophy syndrome. Am J Clin Nutr. 2005 Jun; 81(6):1405-10.
Score: 0.054
-
Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy. Curr Atheroscler Rep. 2004 May; 6(3):173-9.
Score: 0.050
-
Dysregulated energy expenditure in HIV-infected patients: a mechanistic review. Clin Infect Dis. 2007 Jun 01; 44(11):1509-17.
Score: 0.015
-
Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of 'systemic steatosis'. Curr Opin Lipidol. 2004 Feb; 15(1):59-67.
Score: 0.012